Becker's Healthcare May 20, 2019
The rising costs of healthcare and resource constraints are the top two concerns of pharma and healthcare CEOs, according to PricewaterhouseCoopers 22nd annual global CEO survey.
For its survey, PwC conducted 1,378 interviews in September and October 2018 with CEOs in 91 territories.
Five key findings from the survey:
1. Ninety-three percent of healthcare CEOs said rising costs and ensuing pressures on governments, payers and consumers is the top concern. Eighty-one percent of pharma CEOs agreed.
2. Resource constraints, such as a shortage of talent, was the second biggest concern of healthcare and pharma CEOs.
3. Addressing social determinants of health, such as housing, employment and education...
Today's Sponsors
Today's Sponsor